Sheng-Yiao Lin

Evaluation of low‐dose tofacitinib combining narrowband UVB therapy for treating vitiligo patients who had failed previous therapy: A pilot study

Shu-Mei Huang, C. Lan, Wei-Cheng Fang, 2021, Photodermatology, photoimmunology & photomedicine.

Treatment of atopic dermatitis with dupilumab in Taiwan: dynamic changes of IgE levels as a potential response biomarker

Yin-Chun Chen, C. Lan, Ting-Ting Yang, 2019, European Journal of Dermatology.

Dupilumab as a rescue therapy for a chronic urticaria patient who showed secondary failure to omalizumab

C. Lan, Sheng-Yiao Lin, Yng Sun, 2022, The Kaohsiung journal of medical sciences.

Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen

Chao-Chun Yang, C. Lan, Yang-Yi Chen, 2019, EJD. European journal of dermatology.

Low‐dose tofacitinib with 308‐nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo

Shu-Mei Huang, C. Lan, Sheng-Yiao Lin, 2021, Clinical and experimental dermatology.

Simple procedure to evaluate mid‐face sagging: A pilot study from Taiwan

C. Lan, Sheng-Yiao Lin, Pei-Ling Chih, 2020, The Australasian journal of dermatology.